BI 473494

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 473494, covering 2022-06-22 to 2022-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects [Phase 1]